What is GILD's current stock price?

As of now, GILD is trading at $147.23, with a daily change of -2.93%.

What are the risks associated with GILD stock?

GILD has Low, risk level based on volatility, sector strength, volume, investor confidence and outlook.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

GILD Stock Analysis & IQ Rating | Gilead Sciences

GILD

Gilead Sciences

$147.23

-$4.45 | -2.93%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

alert Latest Updates

Night.Owl Yesterday at 08:43

Ford 4th-quarter revenue fell 5% to $45.9 billion, marking its first drop since early fiscal 2025, and the automaker posted its worst earnings miss in four years as tariffs and supplier disruptions pressured margins. Core prof...

GILD Stock IQ

Login to see Gilead Sciences (GILD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

GILD Target Price

Login to display

Strengths

GILD Rewards

Upgraded on attractively valued

GILD Rewards

Trading below its fair value

GILD Rewards

Earnings are forecast to grow

GILD Rewards

Outperform the market

GILD Price Performance

$124.07 (+18.67%)

$124.94 (+17.84%)

$113.62 (+29.58%)

$111.99 (+31.47%)

1year

6month

3month

1month

GILD Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

GILD Analysts Opinion

GILD Analysts opinion is negative and it remained unchanged from the past 3 months

GILD Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

74%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

67%

40%

GILD Street Sentiment

GILD Street Sentiment is extremely bullish and have positive views on the near-term outlook

GILD Risk Level

GILD has Low risk level

Low

LOW

HIGH

GILD Performance Sentiment

Sentiments overview associated with events and the stock performance

74%

23%

Positive

Negative

26 out of 35
events present

8 out of 35
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$149.68

Resistance
Price

$121.26

Current Price Range

$152.50

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

100%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

9

0

Date

Action

Rating

Firm

Jan 12, 2026

Upgrade

the stock

Citi

Dec 13, 2025

Reiterate

Overweight

Morgan Stanley

Dec 10, 2025

Reiterate

Buy

Cantor Fitzgerald

Nov 14, 2025

Initiate

Outperform

Scotiabank

Nov 14, 2025

Reiterate

Buy

Needham

GILD Latest Analysis +

Gilead Sciences (GILD) Surpasses Q4 Earnings and Revenue Estimates. Gilead (GILD) delivered earnings and revenue surprises of 1.91% and 4.63% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Tue Feb 10, 2026

$147.23 | -2.93%

Earnings

Gilead Stock Slips After Q4 Earnings Weak FY26 Guidance. Gilead Sciences Inc. (NASDAQ:GILD) shares slipped in Tuesday'.s extended trading after the company released its fourth-quarter earnings report with weak fiscal 2026 guidance. Here'.s a look at the key figures from the quarter. GILD stock is moving. Watch the price action here.The Details: Gilead

Tue Feb 10, 2026

$147.23 | -2.93%

Momentum

Potential

Gilead Sciences Non-GAAP EPS of $1.86 beats by $0.03 revenue of $7.93B beats by $250M.

Tue Feb 10, 2026

$147.23 | -2.93%

Earnings

Earnings Snapshot: Gilead guides FY26 earnings below consensus after strong Q4.

Tue Feb 10, 2026

$147.23 | -2.93%

Earnings

Gilead Sciences raises quarterly dividend by 3.8% to $0.82/share.

Tue Feb 10, 2026

$147.23 | -2.93%

Activity

Gilead falls despite quarterly beats on disappointing 2026 EPS guidance.

Tue Feb 10, 2026

$147.23 | -2.93%

Momentum

Potential

Gileads Earnings Surprise. HIV Drug Sales Were Strong.

Tue Feb 10, 2026

$147.23 | -2.93%

Earnings

Will Gileads Solid Fourth Quarter Be Enough To Shake Off Its Light Outlook?. Gilead Sciences cleanly beat fourth-quarter expectations late Tuesday but Gilead stock could take a hit on its light guidance for 2026.The post Will Gilead'.s Solid Fourth Quarter Be Enough To Shake Off Its Light Outlook? appeared first on Investor'.s Business Daily.

Tue Feb 10, 2026

$147.23 | -2.93%

Earnings

Potential

Gilead quarterly results beat Wall Street estimates.

Tue Feb 10, 2026

$147.23 | -2.93%

Earnings

Gilead Sciences Profit Rises on Growth of Liver Disease HIV Products. The biopharmaceutical company may start to offer two cancer therapies and an additional HIV treatment option this year.

Tue Feb 10, 2026

$147.23 | -2.93%

Earnings

Momentum

Runners Also Watch

Close Price

Change

CGEN

Compugen

1.76

+2.92%

AGEN

Agenus

3.07

+3.02%

ACLX

Arcellx Inc.

67.24

-2.27%

FAQ About GILD Stock Insights

What is GILD current stock price?

What are GILD stock strengths?

What is GILD Risk Level?

What is GILD market cap and volume?

What is GILD current Stock IQ?

Should I buy GILD stock right now?

Is GILD a Strong Buy right now?

What does a 'Strong Buy' rating mean for GILD?

What does a 'Strong Sell' rating mean for GILD?

What factors influence GILD's Stock IQ?

Explore our GILD Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored GILD Stock Strategies
Effective Risk Management

FIND US ON

Receive our GILD Daily Alerts

Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

GILD

Gilead Sciences

Set Alerts

Current Price

$147.23

-$4.45 | -2.93%

52W High

$153.13

MKT CAP

$186.43B

52W Low

$93.37

VOL

$10.43M

P/E Ratio

22.88

AVG VOL

$7.09M

RSI

68.02

TREND

Uptrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Runners Also Watch

Symbol

Close

Change

CGEN

Compugen

1.76

+2.92%

AGEN

Agenus

3.07

+3.02%

ACLX

Arcellx Inc.

67.24

-2.27%

GILD Price Performance

$124.07 (+18.67%)

$124.94 (+17.84%)

$113.62 (+29.58%)

$111.99 (+31.47%)

1year

6month

3month

1month

GILD Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

GILD Analysts Opinion

GILD Analysts opinion is negative and it remained unchanged from the past 3 months

GILD Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

74%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

67%

40%

GILD Street Sentiment

GILD Street Sentiment is extremely bullish and have positive views on the near-term outlook

GILD Risk Level

GILD has Low risk level

Low

LOW

HIGH

GILD Performance Sentiment

Sentiments overview associated with events and the stock performance.

74%

23%

Positive

Negative

26 out of 35
events present

8 out of 35
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$149.68

Resistance
Price

$121.26

Current Price Range

$152.50

Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

9

0

Date

Action

Rating

Firm

Jan 12, 2026

Upgrade

the stock

Citi

Dec 13, 2025

Reiterate

Overweight

Morgan Stanley

Dec 10, 2025

Reiterate

Buy

Cantor Fitzgerald

Nov 14, 2025

Initiate

Outperform

Scotiabank

Nov 14, 2025

Reiterate

Buy

Needham

GILD Stock IQ

Login to unlock Gilead Sciences (GILD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

GILD Rewards

Upgraded on attractively valued

GILD Rewards

Trading below its fair value

GILD Rewards

Earnings are forecast to grow

GILD Rewards

Outperform the market

GILD Latest Analysis

Night.Owl Yesterday at 08:43

Ford 4th-quarter revenue fell 5% to $45.9 billion, marking its first drop since early fiscal 2025, and the automaker posted its worst earnings miss in four years as tariffs and supplier disruptions pressured margins. Core prof...

Discover GILD Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of GILD. We're here to help you make informed investment decisions today.

FIND US ON

Receive our GILD Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

GILD Stock trends

GILD Stock performance

GILD Stock analysis

GILD investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing GILD

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing GILD

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

GILD Stock Analysis & IQ Rating | Gilead Sciences

GILD Stock IQ

GILD Target Price

GILD Analysts Opinion

GILD Street Sentiment

GILD Risk Level

GILD Performance Sentiment

Key Price Levels

Analyst Consensus

Explore our GILD Stock insights

Receive our GILD Daily Alerts

GILD Street Sentiment

GILD Risk Level

Key Price Levels

Latest Analyst Actions

Discover GILD Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of GILD. We're here to help you make informed investment decisions today.

Receive our GILD Daily Alerts

GILD Alerts